HBV virological suppression: still not enough to save from hepatocellular carcinoma. A case report on a 15-year, real-life story

Tullio Prestileo; Francesco Di Lorenzo; Adriana Sanfilippo; Claudia Imburgia; Giuseppe Cabibbo; Salvatore Corrao

doi:10.1701/2745.27990

HBV virological suppression: still not enough to save from hepatocellular carcinoma. A case report on a 15-year, real-life story

Recenti Prog Med. 2017 Sep;108(9):379-381. doi: 10.1701/2745.27990.

Authors

Tullio Prestileo¹, Francesco Di Lorenzo¹, Adriana Sanfilippo¹, Claudia Imburgia¹, Giuseppe Cabibbo², Salvatore Corrao¹

Affiliations

¹ Department of Internal Medicine, National Hospital Trust, ARNAS Civico di Cristina e Benfratelli, Infection Unit, Palermo, Italy.
² Section of Gastroenterology, DiBiMIS, University of Palermo, Italy.

PMID: 28901347
DOI: 10.1701/2745.27990

Abstract

Among HIV-infected patients worldwide, 2-4 million are chronically infected with HBV. We report a 15-year, real-life story of a patient with HBV-HIV coinfection, who developed HCC despite high treatment adherence and complete viral suppression. The aim of our report is to alert the infectious diseases community to monitor the possible development of HCC regardless of high treatment adherence and complete viral suppression.

Publication types

Case Reports

MeSH terms

Adult
Antiviral Agents / administration & dosage
Carcinoma, Hepatocellular / virology*
Coinfection
HIV Infections / complications*
HIV Infections / virology
Hepatitis B, Chronic / complications*
Hepatitis B, Chronic / drug therapy
Humans
Liver Neoplasms / virology*
Male
Medication Adherence

Substances

Antiviral Agents